Quick Answer
Lipocine Inc. reported Long Term Debt of $2.26 million for the year ending 2020.
- Lipocine Inc. showed a decrease of -40.8% in Long Term Debt from 2019 to 2020.
- This data is from Lipocine Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2022.
- XBRL data for this metric is available from 2017 to 2020 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $8.72 million | Q2 2018: $8.58 million | Q3 2018: $7.85 million | Q1 2019: $6.16 million | Q2 2019: $5.38 million | Q3 2019: $4.60 million | Q1 2020: $4.69 million | Q2 2020: $4.00 million | Q3 2020: $3.15 million | Q1 2021: $1.44 million.
- Historical annual values: Fiscal year 2020: $2.26 million | Fiscal year 2019: $3.81 million | Fiscal year 2018: $6.93 million | Fiscal year 2017: $0.00.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: